Abstract:Cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) is caused by a mutation on the NOTCH3 gene. The pathological driver behind this disease is the loss of vascular smooth muscle cells (VSMCs) in small blood vessels and subsequent fibrotic thickening of the vessel, causing stenosis. Although a great deal of knowledge has been accumulated through CADASIL research, more information is needed to fully grasp the pathological mechanisms as well as understand disease progression. We have focused on the effects of NOTCH3 mutation on VSMCs and identified several novel actors in disease progression. In our initial study, we investigated factors playing a role in the VSMC proliferative rate. We found that VSMCs carrying a CADASIL mutation express higher levels of TGFβ. This elevated cytokine secretion by CADASIL VSMCs had an inhibitory proliferative effect on not only these cells, but also cells in their vicinity. This phenotype was rescued by adding neutralizing TGFβ antibody to the growth media, which increased CADASIL VSMC proliferation rate to that of control VSMCs, while having a minimal effect on control VSMC proliferation rate. One of the initial events in CADASIL disease progression is NOTCH3 aggregation and accumulation. In our next study, we focused on degradation of aggregated NOTCH3 via autophagy processes. After confirming that NOTCH3 is aggregated and accumulated in our cell line, we further tested the autophagy process in these cells. We discovered that the autophagy process in CADASIL VSMCs is interrupted and, upon further investigation, found that this could be due to a dysfunction in fusion of the autophagosome and lysosome. Next, we investigated the nutritional requirements in CADASIL VSMCs compared to control VSMCs. One of the most readily available forms of nutrients in myocytes is glucose. Hence, we examined glucose transporter expression in CADASIL VSMCs compared to control VSMCs. CADASIL VSMC glucose transporters were significantly down regulated and this down regulation had a negative functional effect such that CADASIL VSMCs were unable to take up glucose as avidly as control VSMCs. Adding insulin to the media only moderately increased glucose uptake in CADASIL VSMCs since Glut 4 was the only insulin-dependent glucose transporter that was down regulated (other glucose transporters were also down regulated, but they were insulinindependent). VSMCs in CADASIL are frail and less resistant to stress. Based on this fact, we hypothesized that they may secret inflammatory cytokines and thereby affect their neighboring cells in paracrine fashion. Measuring inflammatory cytokine gene expression, we discovered that most of them were up regulated, which translated to an increased amount of protein synthesis. In this study, we have implicated inflammation as a pathological driver in CADASIL. Dampening of this inflammatory response may slow the rate of VSMC loss and, consequently, disease progression. LIST OF SCIENTIFIC PAPERS I. Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression II. Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells III. Disrupted Glucose metabolism in Brain Myocytes in CADASIL IV. CADASIL mutation in vascular smooth muscle cells cause high inflammatory response in CADASIL

Blood vessel organoids generated by base editing and harboring single nucleotide variation in Notch3 effectively recapitulate CADASIL-related pathogenesis

Modeling CADASIL Vascular Pathologies with Patient-Derived Induced Pluripotent Stem Cells

Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids

Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease

Patient-Specific Ipsc Model of a Genetic Vascular Dementia Syndrome Reveals Failure of Mural Cells to Stabilize Capillary Structures

Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 is Critical for Vascular Development

Novel Pathological Features and Potential Therapeutic Approaches for CADASIL: Insights Obtained from a Mouse Model of CADASIL.

High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins

Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway

CADASIL: A NOTCH3-associated cerebral small vessel disease

Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease

CADASIL : a pure model for studying cerebral small vessel disease

Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids

Stem cell factor and granulocyte colony-stimulating factor exhibit therapeutic effects in a mouse model of CADASIL

Stem cell factor and granulocyte colony-stimulating factor promote brain repair and improve cognitive function through VEGF-A in a mouse model of CADASIL

Vascular Defects Associated with Hereditary Hemorrhagic Telangiectasia Revealed in Patient-Derived Isogenic Ipscs in 3D Vessels on Chip

Notch3 Gene Mutation Results in Hypoplasia of Arterial Smooth Muscle Cells

Heterogeneity of NOTCH3 activation mechanisms uncovers therapeutic potential for targeted therapies for CADASIL.

Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL

ER stress and Rho kinase activation underlie the vasculopathy of CADASIL

CADASIL mutations sensitize the brain to ischemia via spreading depolarizations and abnormal extracellular potassium homeostasis